Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD ▲ | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -0.970% | 1.980% | 26.225% | 52.367% | 18.664% | -32.680% | 5.609% |
| Innoviva Inc. | -0.580% | 4.268% | -0.581% | 43.697% | 19.580% | 39.024% | 76.325% |
| Vertex Pharmaceuticals Inc. | 1.250% | 3.136% | -3.162% | 38.106% | 19.898% | 162.953% | 175.402% |
| Collegium Pharmaceutical Inc | 4.240% | 3.774% | 0.610% | 54.206% | 20.438% | 89.655% | 223.403% |
| Merck KGaA | -0.320% | 2.827% | 5.882% | 5.850% | 21.292% | -12.283% | 82.027% |
| Vanda Pharmaceuticals | -0.420% | -2.479% | -14.955% | -3.673% | 21.649% | -65.547% | - |
| Lumos Pharma Inc. | 2.750% | 28.986% | 72.816% | 36.923% | 21.918% | -60.223% | -72.750% |
| SELLAS Life Sciences Group Inc | 3.240% | 1.880% | 5.300% | -12.094% | 22.256% | -84.873% | -80.117% |
| Brainstorm Cell | 0.360% | -9.400% | -12.245% | -82.421% | 23.673% | -89.946% | -91.560% |
| PTC Therapeutics Inc. | 0.640% | 6.803% | 4.667% | -13.736% | 24.603% | -10.795% | -18.915% |
| Novocure Ltd | -0.620% | 13.414% | -7.204% | -4.034% | 24.974% | -84.392% | -78.485% |
| AbbVie Inc. | -0.030% | -0.351% | 4.867% | 29.985% | 25.810% | 73.861% | 193.767% |
| aTyr Pharma Inc | - | -0.606% | -18.812% | 1.863% | 27.132% | -62.037% | -41.429% |
| Sangamo Therapeutics Inc. | 3.330% | -4.178% | -11.588% | -11.977% | 28.812% | -91.248% | -92.649% |
| AstraZeneca plc | -0.380% | 1.939% | 8.721% | 24.566% | 29.051% | 58.190% | 92.787% |
| Enanta Pharmaceuticals Inc. | 0.880% | 3.636% | -17.986% | -19.149% | 29.545% | -75.641% | -82.090% |
| TG Therapeutics Inc. | 1.600% | -3.370% | 15.906% | 120.904% | 32.130% | -7.498% | 266.621% |
| Santen Pharmaceutical Corp Ltd. | -3.390% | 7.273% | 10.280% | 42.169% | 32.584% | -2.479% | -23.387% |
| Regeneron Pharmaceuticals Inc. | -0.380% | -0.514% | 7.006% | 39.515% | 33.480% | 89.244% | 305.061% |